Showing results (1-10 of 119) with videos related to
Sort By:
Pageof 12
Human Gene Therapy Methods|July 24, 2018
Standardized Method for Intra-Cisterna Magna Delivery Under Fluoroscopic Guidance in Nonhuman PrimatesNathan Katz, Tamara Goode, Christian Hinderer, et al.Toxicologic Pathology|December 13, 2024
Neuropathological Findings in Nonclinical Species Following Administration of Adeno-Associated Virus (AAV)-Based Gene Therapy VectorsBrad Bolon, Elizabeth Buza, Elizabeth Galbreath, et al.Human Gene Therapy|May 31, 2012
Cell and gene therapy for genetic diseases: inherited disorders affecting the lung and those mimicking sudden infant death syndromeAllison M Keeler, Terence R FlotteAnnual Review of Virology|July 9, 2019
Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?Allison M Keeler, Terence R FlotteResearch Square|July 18, 2023
Quantification of human mature frataxin protein expression in nonhuman primate hearts after gene therapyIan Blair, Teerapat Rojsajjakul, Juliette Hordeaux, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2018
The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J MiceJuliette Hordeaux, Qiang Wang, Nathan Katz, et al.Human Gene Therapy|March 22, 2021
CRISPR/Cas-Dependent and Nuclease-Free <i>In Vivo</i> Therapeutic Gene EditingIshani Dasgupta, Terence R Flotte, Allison M KeelerHuman Gene Therapy Methods|March 24, 2017
CAR T-Cell Therapy: Progress and ProspectsOlivia Wilkins, Allison M Keeler, Terence R FlotteBiomedicines|February 25, 2022
CAR-T Regulatory (CAR-Treg) Cells: Engineering and ApplicationsMotahareh Arjomandnejad, Acadia L Kopec, Allison M KeelerPlos One|May 16, 2017
Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphomaPierre Boyé, François Serres, Laurent Marescaux, et al.Pageof 12